person

Libor C.

Country
Czechia
Department
Interni hematologicka a onkologicka klinika FN Brno

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
42
Sites with multiple studies

Has run more than one trial at 42 of 126 partner sites.

Specializations

Hematologic malignancies

Clinical activity is strongly centered on acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, multiple myeloma, myelodysplastic syndromes, and myelofibrosis, with additional involvement in Hodgkin lymphoma, diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma.

  • Acute myeloid leukemia
  • Multiple myeloma
  • Chronic lymphocytic leukemia
  • Lymphoma

The trial portfolio also includes plasma cell disorders, relapsed or refractory disease, and post-transplant maintenance strategies within malignant hematology.

Cardiovascular medicine

Research interests extend to acute myocardial infarction, heart failure, atherosclerotic cardiovascular disease, atrial fibrillation, and hypercholesterolemia, reflecting sustained engagement in both acute and chronic cardiovascular care.

  • Acute myocardial infarction
  • Heart failure
  • Atherosclerotic cardiovascular disease
  • Thrombotic risk

Additional work includes anticoagulation reversal, major adverse cardiovascular events, and cardiometabolic risk in high-risk adult populations.

Autoimmune and inflammatory disorders

The investigator is involved in studies of myasthenia gravis, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriatic arthritis, juvenile idiopathic arthritis, and atopic dermatitis.

  • Myasthenia gravis
  • Multiple sclerosis
  • Inflammatory bowel disease
  • Atopic dermatitis

Therapeutic interest also covers immune thrombocytopenia, autoimmune hemolytic anemia, vasculitis, and other immune-mediated conditions.

Solid tumors and pediatric oncology

Clinical research includes breast cancer, ovarian cancer, endometrial cancer, lung cancer, renal cell carcinoma, prostate cancer, and pancreatic cancer, alongside pediatric malignancies such as medulloblastoma, neuroblastoma, high-risk glioma, and rhabdomyosarcoma.

  • Breast cancer
  • Ovarian cancer
  • Lung cancer
  • Pediatric solid tumors

This area also includes metastatic disease, rare cancers, and tumor-specific targeted therapy across adult and pediatric settings.

Specialized rare diseases and supportive care

Further involvement spans hemophilia, amyloidosis, paroxysmal nocturnal hemoglobinuria, kidney disease, hepatitis D, cystic fibrosis, and sleep apnea, reflecting a broad interest in uncommon and complex disorders.

  • Hemophilia
  • Amyloidosis
  • Paroxysmal nocturnal hemoglobinuria
  • Rare inflammatory and genetic diseases

Additional therapeutic areas include ophthalmic disease, pulmonary disorders, gastrointestinal inflammation, and supportive care for patients with chronic illness.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.